Skip to content

A Comparative Clinical and Radiographic Study Of Collagen Based Pulpotomy in Cariously Exposed Vital Primary Molars

A Comparative Clinical and Radiographic Study Of Collagen Based Pulpotomy Versus MTA Pulpotomy in Cariously Exposed Vital Primary Molars

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05829304
Enrollment
19
Registered
2023-04-25
Start date
2023-06-30
Completion date
2024-06-30
Last updated
2023-04-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dental Caries in Children

Brief summary

To assess post operative pain and survival rate after collagen based pulpotomy versus MTA pulpotomy in children with vital primary molars.

Detailed description

Pulpotomy of vital primary molars is indicated when caries removal results in pulp exposure. Treatment approaches consist of devitalization using formocresol, preservation using ferric sulfate and regeneration using mineral trioxide aggregate of the remaining pulp tissue have been utilized to date. The ideal pulpotomy medicament would be biocompatible and bactericidal, in addition, to promote the healing of the root pulp and be compatible with the physiological process of root resorption. Collagen, which is available for dental implication, is already sterilized and also reinforced with antibiotic particles to efficiently aid in regeneration and repair without any contaminations. The collagen particles can be sterilized by various methods like irradiation, dry heat, and ethylene oxide, among which irradiation is the most frequently used method as it does not affect the structural stability

Interventions

OTHERMTA based pulpotomy

The principal investigator will carry out all treatment procedures, and the patients will be assigned. It will be as split mouth, both groups A&B will be at the same patient.

OTHERCollagen based pulpotomy

The principal investigator will carry out all treatment procedures, and the patients will be assigned. It will be as split mouth, both groups A&B will be at the same patient.

Sponsors

Cairo University
CollaboratorOTHER
sherouk atef elsayed
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Outcomes Assessor)

Masking description

the blinding is not possible (unfortunately) due to the nature of the trial. Trial participants, outcome assessors and statistician will be blinded.

Intervention model description

Teeth that will be included in the current trial will be randomly assigned one of the experimental groups using closed white envelopes (simple randomization 1:1 ratio).

Eligibility

Sex/Gender
ALL
Age
4 Years to 6 Years
Healthy volunteers
Yes

Inclusion criteria

1. Primary molar tooth not more than one-third of root resorption. 2. Children with bilateral deep dental caries approximating the pulp in primary molars assessed both clinically and radiographically. 3. systemically healthy. 4. cooperative patients who will comply to follow up visits.

Exclusion criteria

1. Children with medical, physical, or mental conditions. 2. Primary molars with any congenital deformities. 3. Previously accessed teeth. 4. At operative procedure haemorrhage control is unachievable after pulpotomy.

Design outcomes

Primary

MeasureTime frameDescription
postoperative pain3 dayspostoperative pain following the placement of restoration by questioning the patient. using numerical pain rating scale Zero means patient have no pain, while 10 represents the most intense pain possible.

Secondary

MeasureTime frameDescription
Absence of internal root resorptionup to 24 weekbinary outcome detected with periapical x-ray by parallel technique using XCP film holder
absence of swellingup to 24 weekbinary outcome detected with periapical x-ray by parallel technique using XCP film holder

Contacts

Primary ContactSherouk Elsayed, bachelor
sherouk.elsayed@dentistry.cu.edu.eg+201005544373
Backup Contactpassant nagi, lecturer
passant.nagi@dentistry.cu.edu.eg+201280557107

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026